FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
The FDA on Monday approved the first new treatment for Alzheimer’s disease in nearly two decades, a landmark decision that has been eagerly awaited by millions of Americans diagnosed with the condition but that will be hotly contested by some in the scientific community who doubt the drug’s effectiveness.
Photo via @AlexanderSpinnFDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
BREAKING: FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
The FDA’s approval of $BIIB aducanumab is hugely consequential. FDA granted ACCELERATED APPROVAL based on reduction of beta amyloid — NOT for slowing of cognitive decline in patients.
The full story from STAT here, written by and me:
No comments:
Post a Comment